American Society of Clinical Oncology

SHERPA: White

People

  1. Aghajanian
    Aghajanian
  2. Hensley
    Hensley
  3. Konner
    Konner
  4. Iasonos
    Iasonos
  5. Makker
    Makker
  6. Tew
    Tew
  7. Grisham
    Grisham
  8. O'Cearbhaill
    O'Cearbhaill
  9. Zhou
    Zhou
  10. Sabbatini
    Sabbatini

Groups

  1. Department of Medicine (154)
  2. GDMT, Medicine (154)
  3. Gynecologic Medicine Service (154)
  4. Gynecology Disease Management Team (154)
  5. Solid Tumor Oncology Division (154)
  6. Epidemiology and Biostatistics (42)
  7. Biostatistics Service (37)
  8. Surgery (37)
  9. Hematologic Malignancies, Division of (30)
  10. Department of Pathology and Laboratory Medicine (25)
Search Within
  1. "Carol Aghajanian"
Formats
  1. Meeting Abstract (115)
  2. Journal Article (39)
Groups
  1. Department of Medicine (154)
  2. GDMT, Medicine (154)
  3. Gynecologic Medicine Service (154)
  4. Gynecology Disease Management Team (154)
  5. Solid Tumor Oncology Division (154)
  6. Epidemiology and Biostatistics (42)

More Groups

People
  1. Carol Aghajanian (154)
  2. Paul Sabbatini (40)
  3. Martee Hensley (34)
  4. David Spriggs (31)
  5. Jason Konner (31)
  6. Alexia Iasonos (30)

More People

Years
  1. 2024 (6)
  2. 2023 (9)
  3. 2022 (7)
  4. 2021 (7)
  5. 2020 (13)
  6. 2019 (15)

More Years

Publications
  1. Journal of Clinical Oncology (149)
  2. JCO Precision Oncology (5)

Results (154)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimizing mainstreaming of genetic testing in parallel with ovarian and endometrial cancer tumor testing: How do we maximize our impact?
    Journal Article

    Liu, Y. L.; Sia, T. Y.; Varice, N.; Wu, M.; Byrne, M.; Khurram, A.; Kemel, Y.; Sheehan, M.; Galle, J.; Sabbatini, P.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026)
    Meeting Abstract

    Erickson, B. K.; Enserro, D.; Lankes, H. A.; Dockery, L. E.; Ghamande, S. A.; Oliver, M. T.; Gressel, G. M.; Castellano, T.; Ratner, E.; Deery, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Racial/ethnic distribution of participants in NRG oncology clinical trials: 2014-2023
    Meeting Abstract

    Dignam, J. J.; Romitti, P. A.; Yom, S. S.; Feng, F. Y.; Bradley, J. D.; Mehta, M. P.; Bruner, D. W.; Wenzel, J.; Mamounas, E. P.; George, T. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A pan-cancer analysis of SMARCA4 alterations and the unique clinicogenomic characteristics associated with SMARCA4 mutation types
    Meeting Abstract

    Gormally, M.; Repetto, M.; Jee, J.; Chang, J. C.; Selenica, P.; Gazzo, A.; Richards, A. L.; Donoghue, M.; Aghajanian, C.; Reis-Filho, J. S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I and randomized phase II study of ruxolitinib with frontline neoadjuvant therapy in advanced ovarian cancer: An NRG Oncology Group Study
    Journal Article

    Landen, C. N.; Buckanovich, R. J.; Sill, M. W.; Mannel, R. S.; Walker, J. L.; Disilvestro, P. A.; Mathews, C. A.; Mutch, D. G.; Hernandez, M. L.; Martin, L. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline pathogenic variants and genetic counseling by ancestry in patients with epithelial ovarian cancer
    Journal Article

    Sia, T. Y.; Maio, A.; Kemel, Y. M.; Arora, K. S.; Gordhandas, S. B.; Kahn, R. M.; Salo-Mullen, E. E.; Sheehan, M. A.; Tejada, P. R.; Bandlamudi, C.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Pathogenic germline variants in patients with endometrial cancer across diverse ancestries
    Meeting Abstract

    Liu, Y. L.; Gordhandas, S.; Arora, K.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E. E.; Zhou, Q.; Iasonos, A.; Selenica, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Initial efficacy and safety results from ENGOT-ov60/GOG-3052/RAMP 201: A phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC)
    Meeting Abstract

    Banerjee, S. N.; Ring, K. L.; Van Nieuwenhuysen, E.; Fabbro, M.; Aghajanian, C.; Oaknin, A.; Colombo, N.; Santin, A.; Clamp, A. R.; Moore, K. N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival
    Meeting Abstract

    Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save